Genprex, Inc. (Genprex)

Oncology Corporate Profile

HQ Location

3300 Bee Cave Road Suite 650 #22
Austin, TX 78746

Company Description

Genprex Inc. is a biopharmaceutical company founded to bridge critical gaps in the cancer therapeutics sector by developing products to unlock the potential of proven but limited cancer drugs. The Company is working to expand clinical populations benefitting from targeted, small molecule therapies by using its biologic agents to combine small molecule drugs to promote genome-wide applications of the combination therapy and to participate in expanding proven markets. The Company's biologics are designed to program cells to overcome intrinsic and acquired small molecule drug resistance without additional toxicities and to sensitize cancer cells to small and large molecule cancer drugs.

Website: http://www.genprex.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
oncoprex (+ erlotinib)pan-kinase inhibitorNon Small Cell Lung Cancer (NSCLC)II
oncoprexpan-kinase inhibitorNon Small Cell Lung Cancer (NSCLC)I
oncoprex pan-kinase inhibitorVarious cancer typesPreclinical

View additional information on product candidates here »

Pipeline image

Source


http://www.genprex.com

Recent News Headlines

There are no news items to display